The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass

Anesthesia and Analgesia

Volumn 85, Issue 1, 1997, Pages 16-22

  Kikura, Mutsuhito ^a   Levy, Jerrold H ^a,b   Michelsen, Luis G ^a   Shanewise, Jack S ^a   Bailey, James M ^a   Sadel, Scott M ^a   Szlam, Fania ^a  

^a EMORY CLINIC   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MILRINONE;

ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART SURGERY; HEMODYNAMIC MONITORING; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; MILRINONE; PYRIDONES; VENTRICULAR FUNCTION, LEFT;

EID: 0030837696     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199707000-00004     Document Type: Article

References (23)

1. Weishaar RE, Quade MM, Schenden JA, Evans DB. Relationship between inhibition of cardiac muscle phosphodiesterase, changes in cyclic nucleotide levels, and contractile response for CI-914 and other novel cardiotonics. J Cyclic Nucleotide Protein Phosphor Res 1985;10:551-64.
2. Baim DS, McDowell AV, Cherniles J, et al. Evaluation of a new bipyridine inotropic agent, milrinone, in patients with severe congestive heart failure. N Engl J Med 1983;309:748-56.
3. Colucci WS, Wright RF, Braunwald E. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2. N Engl J Med 1986;314:349-58.
4. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
5. Levy JH, Salmenpera MT, Bailey JM, Ramsay JG. Post operative circulatory control. In: Kaplan JA, ed. Cardiac anesthesia. Philadelphia: WB Saunders, 1993:1171-2.
6. Levy JH, Ramsay J, Bailey JM. Pharmacokinetics and pharmacodynamics of phosphodiesterase-III inhibitors. J Cardiothorac Anesth 1990;4(Suppl 5):7-11.
7. Butterworth JF IV, Hines RL, Royster RL, James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery. Anesth Analg 1995;81: 783-92.
8. Sherry KM, Locke TJ. Use of milrinone in cardiac surgical patients. Cardiovasc Drugs Ther 1993;7:671-5.
9. Bailey JM, Levy JH, Kikura M, et al. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology 1994;81:616-22.
10. Reich DL, Kaplan JA. Hemodynamic monitoring. In: Kaplan JA, ed. Cardiac anesthesia. Philadelphia: WB Saunders, 1993:286.
11. Wyatt HL, Haendchen RV, Meerbaum S, Corday E. Assessment of quantitative methods for 2-dimensional echocardiography. Am J Cardiol 1983;52:396-401.
12. Colan SD, Borow KM, Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 1984;4:715-24.
13. Brodie BR, McLaurin LP, Grossman W. Combined hemodynamic-ultrasonic method for studying left ventricular wall stress: comparison with angiography. Am J Cardiol 1976; 37:864-70.
14. Reichek N, Wilson J, St John Sutton M, et al. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982;65: 99-108.
15. Yin FC. Ventricular wall stress. Circ Res 1981;49:829-42.
16. Benotti JR, Lesko LJ, McCue JE, Alpert JS. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure. Am J Cardiol 1985;56:685-9.
17. Anderson JL, Baim DS, Fein SA, et al. Efficacy and safety of sustained (48 hours) intravenous infusion of milrinone in patients with severe congestive heart failure: a multicenter study. J Am Coll Cardiol 1987;9:711-22.
18. Feneck RO. Effects of variable dose milrinone in patients with low cardiac output after cardiac surgery. Am Heart J 1991;121: 1995-9.
19. Wright EM, Sherry KM. Clinical and haemodynamic effects of milrinone in the treatment of low cardiac output after cardiac surgery. Br J Anaesth 1991;67:585-90.
20. de Bruijn NP, Clements FM. Transesophageal echocardiography. Boston: Martinus Nijhoff, 1987:94-7.
21. Lang RM, Borow KM, Neuman A, Janzen D. Systemic vascular resistance: an unreliable index of left ventricular afterload. Circulation 1986;74:1114-23.
22. Nixon JV, Murray RG, Leonard PD, et al. Effect of large variations in preload on left ventricular performance characteristics in normal subjects. Circulation 1982;65:698-703.
23. Jaski BE, Fifer MA, Wright RF, et al. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: dose-response relationships and comparison to nitroprusside. J Clin Invest 1985;75:643-9.